BRCA2 and peritoneum cancer: This was supported by a combined analysis of BRCA1 and BRCA2 in Kaplan‐Meier analysis with RRBSO having a HR for ovarian/peritoneal cancer of 0.029 (95% CI = 0.009‐0.100, P < .001).